Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10517-005-0389-9.

Title:
Metformin Decelerates Aging and Development of Mammary Tumors in HER-2/neu Transgenic Mice | Bulletin of Experimental Biology and Medicine
Description:
Transgenic FVB/N female mice carrying HER-2/neu mammary cancer gene received metformin (1200 mg/liter) with drinking water 5 days a week starting from the age of 2 months until natural death. Metformin slightly reduced food consumption, but did not change water consumption and dynamics of weight gain. Mean life span of mice increased by 8% (p<0.05), in 10% long-living mice it was prolonged by 13.1%, and the maximum life span was prolonged by 1 month under the effect of metformin in comparison with the control. The rate of populational aging decreased by 2.26 times. The total incidence of mammary adenocarcinoma and their multiplicity did not change under the effect of metformin, while the latency of tumor development increased and the mean diameter of tumors decreased. Hence, we first demonstrated a geroprotective effect of metformin and its suppressive effect towards the development of mammary tumors.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Non-Profit & Charity
  • Science
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

article, metformin, google, scholar, mice, anisimov, aging, mammary, access, privacy, cookies, content, transgenic, bershtein, cancer, pubmed, data, information, publish, search, development, tumors, herneu, life, span, effect, russian, gerontol, analysis, change, log, journal, research, june, egormin, month, open, discover, petersburg, exp, biol, download, author, springer, optional, personal, parties, policy, find, track,

Topics {✒️}

month download article/chapter byulleten’ eksperimental’noi biologii related subjects 2/neu transgenic mice metformin decelerates aging maximum life span privacy choices/manage cookies female mice carrying pubmed  google scholar full article pdf 10% long-living mice populational aging decreased european economic area max plank society conditions privacy policy change water consumption 2/neu access life span wild type accepting optional cookies cancer main content log 2 transgenic fvb/ article bulletin journal finder publish special issue 1 check access instant access google scholar mice increased june 2005 volume 139 tumor development increased author correspondence article log privacy policy personal data medicine aims article cite books a article anisimov optional cookies manage preferences mammary tumors mammary adenocarcinoma june essential cookies cookies skip subscription content similar content data protection

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Metformin Decelerates Aging and Development of Mammary Tumors in HER-2/neu Transgenic Mice
         description:Transgenic FVB/N female mice carrying HER-2/neu mammary cancer gene received metformin (1200 mg/liter) with drinking water 5 days a week starting from the age of 2 months until natural death. Metformin slightly reduced food consumption, but did not change water consumption and dynamics of weight gain. Mean life span of mice increased by 8% (p<0.05), in 10% long-living mice it was prolonged by 13.1%, and the maximum life span was prolonged by 1 month under the effect of metformin in comparison with the control. The rate of populational aging decreased by 2.26 times. The total incidence of mammary adenocarcinoma and their multiplicity did not change under the effect of metformin, while the latency of tumor development increased and the mean diameter of tumors decreased. Hence, we first demonstrated a geroprotective effect of metformin and its suppressive effect towards the development of mammary tumors.
         datePublished:
         dateModified:
         pageStart:721
         pageEnd:723
         sameAs:https://doi.org/10.1007/s10517-005-0389-9
         keywords:
            metformin
            life span
            breast cancer
            transgenic mice
            HER-2/neu
            Biomedicine
            general
            Internal Medicine
            Cell Biology
            Pathology
            Laboratory Medicine
         image:
         isPartOf:
            name:Bulletin of Experimental Biology and Medicine
            issn:
               1573-8221
               0007-4888
            volumeNumber:139
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers-Consultants Bureau
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:V. N. Anisimov
               affiliation:
                     name:Ministry of Health of the Russian Federation
                     address:
                        name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:P. A. Egormin
               affiliation:
                     name:Ministry of Health of the Russian Federation
                     address:
                        name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:L. M. Bershtein
               affiliation:
                     name:Ministry of Health of the Russian Federation
                     address:
                        name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. A. Zabezhinskii
               affiliation:
                     name:Ministry of Health of the Russian Federation
                     address:
                        name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:T. S. Piskunova
               affiliation:
                     name:Ministry of Health of the Russian Federation
                     address:
                        name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:I. G. Popovich
               affiliation:
                     name:Ministry of Health of the Russian Federation
                     address:
                        name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A. V. Semenchenko
               affiliation:
                     name:Max Plank Society
                     address:
                        name:Institute of Demographic Studies, Max Plank Society, Rostok, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Metformin Decelerates Aging and Development of Mammary Tumors in HER-2/neu Transgenic Mice
      description:Transgenic FVB/N female mice carrying HER-2/neu mammary cancer gene received metformin (1200 mg/liter) with drinking water 5 days a week starting from the age of 2 months until natural death. Metformin slightly reduced food consumption, but did not change water consumption and dynamics of weight gain. Mean life span of mice increased by 8% (p<0.05), in 10% long-living mice it was prolonged by 13.1%, and the maximum life span was prolonged by 1 month under the effect of metformin in comparison with the control. The rate of populational aging decreased by 2.26 times. The total incidence of mammary adenocarcinoma and their multiplicity did not change under the effect of metformin, while the latency of tumor development increased and the mean diameter of tumors decreased. Hence, we first demonstrated a geroprotective effect of metformin and its suppressive effect towards the development of mammary tumors.
      datePublished:
      dateModified:
      pageStart:721
      pageEnd:723
      sameAs:https://doi.org/10.1007/s10517-005-0389-9
      keywords:
         metformin
         life span
         breast cancer
         transgenic mice
         HER-2/neu
         Biomedicine
         general
         Internal Medicine
         Cell Biology
         Pathology
         Laboratory Medicine
      image:
      isPartOf:
         name:Bulletin of Experimental Biology and Medicine
         issn:
            1573-8221
            0007-4888
         volumeNumber:139
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers-Consultants Bureau
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:V. N. Anisimov
            affiliation:
                  name:Ministry of Health of the Russian Federation
                  address:
                     name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:P. A. Egormin
            affiliation:
                  name:Ministry of Health of the Russian Federation
                  address:
                     name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:L. M. Bershtein
            affiliation:
                  name:Ministry of Health of the Russian Federation
                  address:
                     name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. A. Zabezhinskii
            affiliation:
                  name:Ministry of Health of the Russian Federation
                  address:
                     name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:T. S. Piskunova
            affiliation:
                  name:Ministry of Health of the Russian Federation
                  address:
                     name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:I. G. Popovich
            affiliation:
                  name:Ministry of Health of the Russian Federation
                  address:
                     name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A. V. Semenchenko
            affiliation:
                  name:Max Plank Society
                  address:
                     name:Institute of Demographic Studies, Max Plank Society, Rostok, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Bulletin of Experimental Biology and Medicine
      issn:
         1573-8221
         0007-4888
      volumeNumber:139
Organization:
      name:Kluwer Academic Publishers-Consultants Bureau
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Ministry of Health of the Russian Federation
      address:
         name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
         type:PostalAddress
      name:Ministry of Health of the Russian Federation
      address:
         name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
         type:PostalAddress
      name:Ministry of Health of the Russian Federation
      address:
         name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
         type:PostalAddress
      name:Ministry of Health of the Russian Federation
      address:
         name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
         type:PostalAddress
      name:Ministry of Health of the Russian Federation
      address:
         name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
         type:PostalAddress
      name:Ministry of Health of the Russian Federation
      address:
         name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
         type:PostalAddress
      name:Max Plank Society
      address:
         name:Institute of Demographic Studies, Max Plank Society, Rostok, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:V. N. Anisimov
      affiliation:
            name:Ministry of Health of the Russian Federation
            address:
               name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:P. A. Egormin
      affiliation:
            name:Ministry of Health of the Russian Federation
            address:
               name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
               type:PostalAddress
            type:Organization
      name:L. M. Bershtein
      affiliation:
            name:Ministry of Health of the Russian Federation
            address:
               name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
               type:PostalAddress
            type:Organization
      name:M. A. Zabezhinskii
      affiliation:
            name:Ministry of Health of the Russian Federation
            address:
               name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
               type:PostalAddress
            type:Organization
      name:T. S. Piskunova
      affiliation:
            name:Ministry of Health of the Russian Federation
            address:
               name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
               type:PostalAddress
            type:Organization
      name:I. G. Popovich
      affiliation:
            name:Ministry of Health of the Russian Federation
            address:
               name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
               type:PostalAddress
            type:Organization
      name:A. V. Semenchenko
      affiliation:
            name:Max Plank Society
            address:
               name:Institute of Demographic Studies, Max Plank Society, Rostok, Germany
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
      name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
      name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
      name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
      name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
      name:Prof. N. N. Petrov Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia
      name:Institute of Demographic Studies, Max Plank Society, Rostok, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(56)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.27s.